Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response

التفاصيل البيبلوغرافية
العنوان:	Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response
المؤلفون:	Kovalchin, J., Krieger, J., Genova, M., Collins, K., Augustyniak, M., Masci, A., Hittinger, T., Kuca, B., Edan, G., Braudeau, C., Rimbert, M., Patel, U., Mascioli, E., Zanelli, E.
المصدر:	In Journal of Neuroimmunology 2010 225(1):153-163
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	01655728
DOI:	10.1016/j.jneuroim.2010.04.008